Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
CBT 200 Follows the Market Down. More details...
Hurricane Fears Force Prices Lower. More details...
CBT 200 Books a Gain. More details...
Biotech Ends Q3 With Gain. More details...
CBT 200 Rises 22 Points. More details...
CBT 200 Stays Positive, Barely. More details...
Dominated by Cancer and Viral Disease Focus. More details...
LymphoStat-B Effective In Large Subgroup. More details...
Pandemic Worries Resurrect Discarded Drug. More details...
Do Pharma and Doctors Have Your Best Interests At Heart?....
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
